Gasser, Rodolfo,Hernandez, Maria-Clemencia,Thomas, Andrew
申请号：
AU2011325190
公开号：
AU2011325190B2
申请日:
2011.11.01
申请国别(地区):
AU
年份:
2015
代理人:
摘要：
The present invention relates to the pharmaceutical use of selective GABA A α5 negative allosteric modulators for the treatment, prevention and/or delay of progression of central nervous system (CNS) conditions related to excessive GABAergic inhibition in the brain.
